Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether acetaminophen (APAP), N-acetylcysteine
(NAC), and APAP in combination with NAC will inhibit lipid peroxidation in aneurysmal
subarachnoid hemorrhage (aSAH), utilizing F2-IsoPs as biomarkers for lipid peroxidation.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Medical Center
Collaborators:
National Institute of General Medical Sciences (NIGMS) National Institutes of Health (NIH)